Quick Answer
Structure Therapeutics Inc. reported Shares Outstanding of 212.51 million shares for fiscal year 2025.
Structure Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 212.51M | +23.7% |
| 2024 | 171.86M | +23.4% |
| 2023 | 139.22M | +1222.5% |
| 2022 | 10.53M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 182.03M | +6.0% | +5.4% |
| June 30, 2025 | 172.70M | +0.6% | +0.1% |
| March 31, 2025 | 172.61M | +23.4% | +0.4% |
| December 31, 2024 | 171.86M | +23.4% | +0.1% |
| September 30, 2024 | 171.76M | — | +0.1% |
| June 30, 2024 | 171.59M | — | +22.7% |
| March 31, 2024 | 139.85M | +21.9% | +0.5% |
| December 31, 2023 | 139.22M | +1222.5% | +21.3% |
- Structure Therapeutics Inc. showed an increase of +23.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Structure Therapeutics Inc.’s shares outstanding has grown by 1918.7% (from 10.53 million shares to 212.51 million shares).
- The most recent figure is from Structure Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: